These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 29898863

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
    Lefebvre MC, St-Onge M, Glazer-Cavanagh M, Bell L, Kha Nguyen JN, Viet-Quoc Nguyen P, Tannenbaum C.
    Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
    Martinez BK, Sood NA, Bunz TJ, Coleman CI.
    J Am Heart Assoc; 2018 Apr 13; 7(8):. PubMed ID: 29654196
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
    Kim D, Yang PS, Sung JH, Jang E, Yu HT, Kim TH, Uhm JS, Kim JY, Pak HN, Lee MH, Lip GYH, Joung B.
    Stroke; 2022 Jun 13; 53(6):1873-1882. PubMed ID: 35109686
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty.
    Shinohara M, Wada R, Yao S, Yano K, Akitsu K, Koike H, Kinoshita T, Yuzawa H, Suzuki T, Fujino T, Ikeda T.
    J Arrhythm; 2019 Dec 13; 35(6):795-803. PubMed ID: 31844468
    [Abstract] [Full Text] [Related]

  • 8. Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence Registry).
    Wong JM, Maddox TM, Kennedy K, Shaw RE.
    Am J Cardiol; 2020 May 15; 125(10):1500-1507. PubMed ID: 32276760
    [Abstract] [Full Text] [Related]

  • 9. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
    Palamaner Subash Shantha G, Bhave PD, Girotra S, Hodgson-Zingman D, Mazur A, Giudici M, Chrischilles E, Vaughan Sarrazin MS.
    Circ Cardiovasc Qual Outcomes; 2017 Apr 15; 10(4):. PubMed ID: 28408716
    [Abstract] [Full Text] [Related]

  • 10. Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients.
    Lamberts M, Staerk L, Olesen JB, Fosbøl EL, Hansen ML, Harboe L, Lefevre C, Evans D, Gislason GH.
    J Am Heart Assoc; 2017 Feb 14; 6(2):. PubMed ID: 28196815
    [Abstract] [Full Text] [Related]

  • 11. Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients.
    Deitelzweig S, Luo X, Gupta K, Trocio J, Mardekian J, Curtice T, Lingohr-Smith M, Menges B, Lin J.
    Curr Med Res Opin; 2017 Oct 14; 33(10):1745-1754. PubMed ID: 28849676
    [Abstract] [Full Text] [Related]

  • 12. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
    Halvorsen S, Ghanima W, Fride Tvete I, Hoxmark C, Falck P, Solli O, Jonasson C.
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan 14; 3(1):28-36. PubMed ID: 27680880
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS, Lip GY.
    Prog Cardiovasc Dis; 2015 Jan 14; 58(2):177-94. PubMed ID: 26162958
    [Abstract] [Full Text] [Related]

  • 15. Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis.
    Deitelzweig S, Farmer C, Luo X, Li X, Vo L, Mardekian J, Fahrbach K, Ashaye A.
    Curr Med Res Opin; 2018 Mar 14; 34(3):487-498. PubMed ID: 29188721
    [Abstract] [Full Text] [Related]

  • 16. Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population.
    Amin A, Keshishian A, Trocio J, Dina O, Le H, Rosenblatt L, Liu X, Mardekian J, Zhang Q, Baser O, Vo L.
    Curr Med Res Opin; 2017 Sep 14; 33(9):1595-1604. PubMed ID: 28635338
    [Abstract] [Full Text] [Related]

  • 17. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF, Chan YH, Chiang CE, Tuan TC, Liao JN, Chen TJ, Lip GYH, Chen SA.
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct 26; 8(7):730-738. PubMed ID: 34694379
    [Abstract] [Full Text] [Related]

  • 18. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW, Barillari G.
    J Clin Pharm Ther; 2014 Apr 26; 39(2):118-35. PubMed ID: 24383983
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillation.
    Søgaard M, Ording AG, Skjøth F, Larsen TB, Nielsen PB.
    Eur Heart J Cardiovasc Pharmacother; 2024 Feb 23; 10(2):137-146. PubMed ID: 37993415
    [Abstract] [Full Text] [Related]

  • 20. Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Decade of Experience.
    Spruit JR, de Vries TAC, Hemels MEW, Pisters R, de Groot JR, Jansen RWMM.
    Drugs Aging; 2024 Sep 23; 41(9):725-740. PubMed ID: 39141209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.